Find policies, billing codes, payers, states, and providers
CPT 96415: Additional Hour Intravenous Chemotherapy Infusion
Headline: CPT code 96415: Add-on IV Chemotherapy Infusion Hourly Extension
Lead: CPT code 96415 is an add-on code used to report each additional hour of intravenous chemotherapy infusion beyond the initial hour in the same session. It captures extended-duration infusion time and is relevant to oncology providers, infusion centers, and payers managing chemotherapy service utilization.
CPT code 96415 represents continued administration of a chemotherapy agent using an infusion technique and is billed per additional hour after the first hour. Nationally, accurate use of this code affects claims adjudication, service-level reporting, and reimbursement for extended infusion encounters in outpatient infusion centers and hospital outpatient departments. It also informs capacity and resource planning for oncology infusion services.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a concise review of coding context, payer coverage patterns, common clinical settings, and how this add-on code relates to primary infusion codes used for the initial hour.
Readers will learn how CPT code 96415 is intended to be applied, the clinical contexts that typically generate its use, and where it fits alongside related infusion codes. The summary includes benchmark considerations and policy-relevant points affecting claims processing and service reporting for extended chemotherapy infusions.
Customize your policy alerts
Sign up for cpt 96415 policy alerts
Get alerted when payer policies referencing 96415 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 96415 describes an add-on chemotherapy infusion service used when a provider continues intravenous administration of a chemotherapy drug beyond the initial hour during the same treatment session. This code is billed for each additional hour of infusion after the first hour.
Service Type: Intravenous chemotherapy infusion, add-on (each additional hour beyond initial hour)
Typical Site of Service: Outpatient infusion center or hospital outpatient department, where extended-duration intravenous chemotherapy infusions are administered.
National Reimbursement Benchmarks
Nationally, Medicare averages $29.4 for CPT 96415 while BUCA’s mean commercial rate is substantially higher at $82.7, reflecting a roughly $53.3 gap between public and this commercial benchmark. Blue Cross Blue Shield’s mean of $101.6 and Aetna’s mean of $77.1 also sit above Medicare, while Cigna and UnitedHealth Group have means closer to BUCA and below BCBS, illustrating a clear separation between Medicare and major commercial payers.
Dispersion measured as the interquartile spread (P75 minus P25) varies meaningfully: Aetna’s IQR is $50.5, Blue Cross Blue Shield’s is $40.1, BUCA’s is $37.8, Cigna’s is $33.8, and UnitedHealth Group’s is $25.0. UnitedHealth Group therefore shows the tightest middle distribution and Aetna the widest, with BUCA and BCBS indicating moderate commercial variability around their means.